Scientists test First-Ever shot against parasitic worm disease
NCT ID NCT05762393
Summary
This study was the first human test of a new vaccine candidate called SchistoShield®, designed to prevent schistosomiasis, a serious parasitic disease. Researchers gave 120 healthy adults in Burkina Faso and Madagascar three different doses of the vaccine or a placebo to check for safety and to see if it triggered an immune response. The main goal was to find a safe dose and see how well the body's defenses reacted to the vaccine.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SCHISTOSOMIASIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Groupe de Recherche Action en Santé (GRAS)
Ouagadougou, Burkina Faso
-
Madagascar Institute for Vaccine Research (University of Antananarivo)
Antananarivo, Madagascar
Conditions
Explore the condition pages connected to this study.